news and events

Biomedical Inventions

Participate in a two-course sequence at Mass. General Hospital

HST 211: Biomedical Inventions-Clinical Introduction offered January 2014

HST 212: Biomedical Inventions-Clinical Experience and Selected Success Analysis  offered Spring 2014

(click course names above for details)


R. Rox Anderson, M.D.

Dr. Anderson graduated from MIT, and then received his MD degree magna cum laude from the joint MIT-Harvard medical program, Health Sciences and Technology.  After completing his dermatology residency and an NIH research fellowship at Harvard, he joined the faculty where he is now Harvard Medical School Professor in dermatology, Director of the Wellman Center for Photomedicine; and adjunct Professor of Health Sciences and Technology at MIT.  Dr. Anderson conceived and developed many of the non-scarring laser treatments now widely used in medical care.  These include treatments for birthmarks, microvascular and pigmented lesions, tattoo and permanent hair removal.  He has also contributed to treatment for vocal cords, kidney stones, glaucoma, heart disease, photodynamic therapy for cancer and acne, and optical diagnostics.  His research has advanced the basic knowledge of human skin photobiology, drug photosensitization mechanisms, tissue optics, and laser-tissue interactions.  In addition to research at the Wellman Center, Dr. Anderson practices dermatology at Massachusetts General Hospital and teaches at Harvard and MIT. Active research includes diagnostic tissue imaging and spectroscopy, photodynamic therapy, mechanisms of selective laser-tissue interactions, adipose tissue biology and novel therapy for skin disorders. Dr. Anderson has been awarded over 60 national and international patents, and has co-authored over 250 scientific books and papers.

Warren M. Zapol, M.D.

Dr. Warren M. Zapol graduated from MIT, and then received his MD degree from the University of Rochester School of Medicine. After a fellowship at NIH, studying laboratory and clinical applications of membrane oxygenators he completed a residency in Anesthesia at MGH. He joined the faculty where he is now the emeritus Anesthetist-in-Chief at Massachusetts General Hospital and the Reginald Jenney Professor of Anaesthesia at Harvard Medical School.  He is currently the Director of the MGH Anesthesia Center for Critical Care Research.  Dr. Zapol’s research efforts include studies of extracorporeal membrane oxygenation (ECMO), acute respiratory distress syndrome, and cardiopulmonary physiology in animals and humans.  Supported by the National Science Foundation, he has led nine Antarctic expeditions to study the diving mechanisms and adaptations of the Weddell seal.  Through that research his team learned how marine mammals avoid the bends and hypoxia during prolonged free diving.  In 2003, he was awarded the Intellectual Property Owners Association’s Inventor of the Year Award for the treatment of hypoxic human newborns with inhaled nitric oxide, a technique now used to save the lives of about 15,000 babies each year in the USA that he pioneered with his MGH team.  In 2006, a steep mountain glacier in Antarctica was named for Dr. Zapol by the United States Board on Geographic Names.  In 2008, he was appointed by President George W. Bush and in 2012 reappointed by President Barack Obama as an academic representative to the U.S. Arctic Research Commission.  In 2012, he was designated as a Distinguished Scientist by the American Heart Association.